Cecelia Damask, DO
Otolaryngology · Orlando, FLNPI 1790756955
Payments from drug & device makers
Across 1,068 payments — averaging $721.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$291K
- GSK$156K
- Regeneron Healthcare Solutions, Inc.$136K
- AstraZeneca$63K
- Optinose US, Inc.$52K
- Sanofi US Services Inc.$32K
- plus $42K from 26 others
Across 11 payments — averaging $1757.63 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- F. Hoffmann-la Roche AG$9K
- AstraZeneca$9K
- GSK$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 263 | $290,743 |
| GSK | 169 | $155,855 |
| Regeneron Healthcare Solutions, Inc. | 148 | $135,763 |
| AstraZeneca | 127 | $62,805 |
| Optinose US, Inc. | 119 | $52,269 |
| Sanofi US Services Inc. | 3 | $31,800 |
| Grifols USA, LLC | 10 | $9,677 |
| Regeneron | 8 | $8,280 |
| Genentech USA, Inc. | 50 | $7,976 |
| Alk-abello, Inc | 30 | $4,411 |
| Genentech, Inc. | 9 | $4,301 |
| Astrazeneca UK Limited | 1 | $1,880 |
| Novartis | 61 | $1,793 |
| Grifols Shared Services North America, Inc. | 1 | $1,425 |
| Amgen | 21 | $343 |
| Teva Pharmaceuticals USA, Inc. | 13 | $329 |
| Sanofi-aventis U.S. LLC | 6 | $290 |
| Pfizer | 6 | $203 |
| Galderma Laboratories, L.p. | 3 | $156 |
| ARS Pharmaceuticals Operations, Inc. | 5 | $110 |
| Iotamotion, Inc. | 2 | $85 |
| Boehringer Ingelheim | 2 | $55 |
| Kaleo, Inc. | 2 | $41 |
| Inspire Medical Systems, Inc. | 1 | $32 |
| Phathom Pharmaceuticals, Inc. | 1 | $30 |
| Med-el Corporation | 1 | $27 |
| Johnson & Johnson | 1 | $20 |
| Phadia US Inc. | 1 | $19 |
| Hikma Pharmaceuticals USA | 1 | $18 |
| Stryker | 1 | $17 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| Merck | 1 | $15 |
How this compares
$770,783 in reported general payments places this provider in the 95th percentile of 586 otolaryngology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other otolaryngology in Orlando
- Charles HughesOrlando$184K
- Craig ShapiroHollywood$8.1M
- Adrien EshraghiMiami$2.1M
- Ralph TufanoSarasota$733K
- Mitchell MillerClearwater$709K
- Brian KerrGainesville$629K
- Maria SuurnaMiami$456K
- Mark TaborTampa$348K
- Franklin RimellFort Myers$314K
- Tapan PadhyaTampa$314K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.